Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Change in Accured Expenses (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Change in Accured Expenses for 7 consecutive years, with $33.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 354.76% to $33.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.2 million, a 119.79% decrease, with the full-year FY2025 number at -$5.2 million, down 119.79% from a year prior.
  • Change in Accured Expenses was $33.1 million for Q4 2025 at Select Medical Holdings, up from $1.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $91.5 million in Q2 2024 to a low of -$158.0 million in Q4 2021.
  • A 5-year average of $2.3 million and a median of $68500.0 in 2023 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: tumbled 1272.8% in 2024, then skyrocketed 354.76% in 2025.
  • Select Medical Holdings' Change in Accured Expenses stood at -$158.0 million in 2021, then soared by 74.99% to -$39.5 million in 2022, then surged by 259.71% to $63.1 million in 2023, then tumbled by 120.62% to -$13.0 million in 2024, then surged by 354.76% to $33.1 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Change in Accured Expenses are $33.1 million (Q4 2025), $1.2 million (Q3 2025), and -$3.3 million (Q2 2025).